← Back to Search

Cost-Benefit Frame for Coronavirus

N/A
Waitlist Available
Led By Marcella Alsan, MD, MPH, PhD
Research Sponsored by Harvard University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All participants who are aged 18 or above and speak English or Spanish
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this outcome will be assessed during the 20-minute baseline survey.
Awards & highlights

Study Summary

This study is evaluating whether flyers can be used to help identify trusted individuals or organizations that could be used in follow-up work to send messages.

Eligible Conditions
  • Coronavirus
  • Infectious Diseases

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this outcome will be assessed during the 20-minute baseline survey.
This trial's timeline: 3 weeks for screening, Varies for treatment, and this outcome will be assessed during the 20-minute baseline survey. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Demographic characteristics of participants assigned into each treatment arm
Effect of a government frame in reducing unit response 1
Effect of a government frame in reducing unit response 2
+7 more

Trial Design

16Treatment groups
Experimental Treatment
Group I: Researchers/Low Incentive/Racial/Ethnic FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing the involvement of academic researchers and a $10 incentive. Then the participant is assigned to be a message that emphasizes the disproportionate impact of COVID-19 on certain ethnic and racial groups.
Group II: Researchers/Low Incentive/No Message FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing the involvement of academic researchers and a $10 incentive. Then the participant is assigned to the arm that provides no messaging.
Group III: Researchers/Low Incentive/Duty FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing the involvement of academic researchers and a $10 incentive. Then the participant is assigned to be a message that emphasizes an individual's responsibility to their community (i.e. duty frame).
Group IV: Researchers/Low Incentive/Cost-Benefit FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing the involvement of academic researchers and a $10 incentive. Then the participant is assigned to be a message that emphasizes the public health benefits of answering the survey questions (i.e. cost-benefit frame).
Group V: Researchers/High Incentive/Racial/Ethnic FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing the involvement of academic researchers and a $20 incentive. Then the participant is assigned to be a message that emphasizes the disproportionate impact of COVID-19 on certain ethnic and racial groups.
Group VI: Researchers/High Incentive/No Message FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing the involvement of academic researchers and a $20 incentive. Then the participant is assigned to the arm that provides no messaging.
Group VII: Researchers/High Incentive/Duty FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing the involvement of academic researchers and a $20 incentive. Then the participant is assigned to be a message that emphasizes an individual's responsibility to their community (i.e. duty frame).
Group VIII: Researchers/High Incentive/Cost-Benefit FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing the involvement of academic researchers and a $20 incentive. Then the participant is assigned to be a message that emphasizes the public health benefits of answering the survey questions (i.e. cost-benefit frame).
Group IX: Government/Low Incentive/Racial/Ethnic FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing government involvement and a $10 incentive. Then the participant is assigned to be a message that emphasizes the disproportionate impact of COVID-19 on certain ethnic and racial groups.
Group X: Government/Low Incentive/No Message FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing government involvement and a $10 incentive. Then the participant is assigned to the arm that provides no messaging.
Group XI: Government/Low Incentive/Duty FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing government involvement and a $10 incentive. Then the participant is assigned to be a message that emphasizes an individual's responsibility to their community (i.e. duty frame).
Group XII: Government/Low Incentive/Cost-Benefit FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing government involvement and a $10 incentive. Then the participant is assigned to be a message that emphasizes the public health benefits of answering the survey questions (i.e. cost-benefit frame).
Group XIII: Government/High Incentive/Racial/Ethnic FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing government involvement and a $20 incentive. Then the participant is assigned to be a message that emphasizes the disproportionate impact of COVID-19 on certain ethnic and racial groups.
Group XIV: Government/High Incentive/No Message FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing government involvement and a $20 incentive. Then the participant is assigned to the arm that provides no messaging.
Group XV: Government/High Incentive/Duty FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing government involvement and a $20 incentive. Then the participant is assigned to be a message that emphasizes an individual's responsibility to their community (i.e. duty frame).
Group XVI: Government/High Incentive/Cost-Benefit FrameExperimental Treatment3 Interventions
The participant is assigned to receive a flyer that includes a message emphasizing government involvement and a $20 incentive. Then the participant is assigned to be a message that emphasizes the public health benefits of answering the survey questions (i.e. cost-benefit frame).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Duty Frame
2020
N/A
~570
Racial/Ethnic Frame
2020
N/A
~570
A $20 Survey Incentive
2020
N/A
~570
Emphasis of Government Involvement
2020
N/A
~570
Emphasis of Academic Researchers Involvement
2020
N/A
~570
Cost-Benefit Frame
2020
N/A
~570
No Messaging
2020
N/A
~570
A $10 Survey Incentive
2020
N/A
~570

Find a Location

Who is running the clinical trial?

Government of Minnesota Office of Management and BudgetUNKNOWN
Abdul Latif Jameel Poverty Action LabOTHER
27 Previous Clinical Trials
181,981 Total Patients Enrolled
Harvard UniversityLead Sponsor
229 Previous Clinical Trials
473,944 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Minnesota
How old are they?
18 - 65
What site did they apply to?
Community Emergency Assistance Programs
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Minnesota COVID-19 Testing Project
Marcella Alsan 2020. "Minnesota COVID-19 Testing Project". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04568889.
~125 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top